| Francine J Baliao, PHARMD | |
|
1360 E Town Rd, Milford, CT 06460-3623 | |
| (203) 877-1912 | |
| Not Available |
| Full Name | Francine J Baliao |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1360 E Town Rd, Milford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326750613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PCT.0016092 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Francine J Baliao, PHARMD 55 Soundview Ave, Stamford, CT 06902-6111 Ph: (203) 424-7081 | Francine J Baliao, PHARMD 1360 E Town Rd, Milford, CT 06460-3623 Ph: (203) 877-1912 |
News Archive
Blood pressure and cholesterol lowering drugs continue to improve survival in patients with hypertension after more than a decade, according to late breaking results from the ASCOT Legacy study presented at ESC Congress 2018 and published in The Lancet.
New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p<0.0001). These findings were presented by investigators at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).
Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.
To help the nation-and the world-understand and prepare for contagious outbreaks, the National Institutes of Health's Models of Infectious Disease Agent Study (MIDAS) adds new research expertise to increase its capacity to simulate disease spread, evaluate different intervention strategies and help inform public health officials and policymakers.
In a recent study, published on the bioRxiv* preprint server, researchers identified human LRRC15 as an inhibitory receptor for SARS-CoV-2 entry, which directly binds to the receptor-binding domain (RBD) of the spike protein with a moderate affinity and inhibits spike-mediated entry.
› Verified 7 days ago
Jane Leila Setias, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1083 Boston Post Rd, Milford, CT 06460 Phone: 203-878-7265 | |
Roman Kowcz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 E Town Rd, Milford, CT 06460 Phone: 203-877-1912 Fax: 203-874-7438 | |
Dr. Daniel Evan Shapiro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 541 Bridgeport Ave, Wallgreens #6503, Milford, CT 06460 Phone: 203-876-7643 | |
Mr. Konstantinos Melanidis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Boston Post Rd, Milford, CT 06460 Phone: 203-701-3051 | |
Mr. Marc Shapiro, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1083 Boston Post Rd, Milford, CT 06460 Phone: 203-878-7265 | |
Jeannette Lynn Moran, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 855 Bridgeport Ave, Milford, CT 06460 Phone: 203-876-0654 Fax: 844-411-6456 | |
Alexander Deraps, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 E Town Rd, Milford, CT 06460 Phone: 802-338-5887 |